1.
Off-label use of orphan medicinal products: a Belgian qualitative study
2.
3.
4.
5.
6.
Estimating the broader fiscal consequences of acute hepatic porphyria (AHP) with recurrent attacks in Belgium using a public economic analytic framework
Additional file 1 of Estimating the broader fiscal consequences of acute hepatic porphyria (AHP) with recurrent attacks in Belgium using a public economic analytic framework